Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. - Wikidata - wikimedia - TriplyDB

Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.

Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.

http://www.wikidata.org/entity/Q37091001

about

Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats.β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure.Mouse strain determines cardiac growth potential.Exercise protects against chronic β-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthase.Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.Delonix regia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case-Control Study in a Finnish Population-The TAMRISK Study β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy Cardioprotective Action of Ginkgo biloba Extract against Sustained β-Adrenergic Stimulation Occurs via Activation of M2/NO Pathway.Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy.Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes.Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes.Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity.Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity.Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice.Comprehensive metabonomic analysis of heart tissue from isoproterenol-induced myocardial infarction rat based on reversed-phase and hydrophilic interaction chromatography coupled to mass spectrometry.Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.l-Arginine Attenuates Cardiac Dysfunction, But Further Down-Regulates α-Myosin Heavy Chain Expression in Isoproterenol-Induced Cardiomyopathy.Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway

P2860

Q33587189-3E5E16CA-8CDE-49A3-BB53-C1977ABC8A15 Q34071906-4729B766-CBD1-4766-84D6-D478904D04A9 Q34935217-CFA17CCE-5649-4C0C-B59D-C3DBB997E767 Q35165245-2D558C8B-F3B4-480D-A997-55E41B705591 Q35683329-CCC49D71-DF62-4C22-9560-B365AA697D8B Q36218052-B2F9B35F-5BB4-4F4F-927E-C6122D5A82B3 Q36299263-BFE6615C-C4C6-4D48-A317-919658FE0C69 Q38266154-596253CC-F5C4-4990-BC61-D51F5E6C37C5 Q38759008-EEA39440-39D5-45E5-8E8D-CA565E85F083 Q39823505-380627C4-3B87-47DD-B9ED-B139B41A70FD Q41682898-2A63B158-9A73-4802-BE73-7637062773F1 Q41864380-43F18B2A-358F-4AF8-A336-7056C59915F1 Q42467954-592DA987-A329-4F29-B4CC-7995F33DE21F Q42472660-825E6D1E-89E7-4245-95FC-16F6182B7EAF Q42503629-47AD7D77-C38B-44F2-888D-DF3A098BF1FF Q42591255-82B49B62-5794-46BF-B303-17551958C1A4 Q42710195-C4BF2C6A-238A-4E29-A498-A545190A3104 Q43074266-399473AB-CEA7-4A30-A43C-0062F987D08E Q47963339-1121968F-0FB8-44E1-A9C9-818490864D37 Q48329169-25379861-57EB-4278-AE58-E5869C239C24 Q48397379-4418FA62-2A22-413D-9419-00625A44A542 Q53546010-72DBB8C0-8930-4BDD-8787-F7AB69245102 Q57146155-7BD6A69F-C606-481E-97F6-895A36A66D8E Q57825824-007475CB-11EF-4526-95E5-10DC88B25DCC Q58785858-BC83D11B-28AD-41EF-AAD7-F0CDD690C01B

P2860

Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.

http://www.wikidata.org/entity/Q37091001

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Isoproterenol-induced heart fa ...... terations of cardiac function.

@en

Isoproterenol-induced heart fa ...... terations of cardiac function.

@nl

type

label

Isoproterenol-induced heart fa ...... terations of cardiac function.

@en

Isoproterenol-induced heart fa ...... terations of cardiac function.

@nl

prefLabel

Isoproterenol-induced heart fa ...... terations of cardiac function.

@en

Isoproterenol-induced heart fa ...... terations of cardiac function.

@nl

P1433

Q37091001-1D0F5305-1AD6-45E1-AD58-29A7C43340E2

P1476

Q37091001-8F707EC6-AE08-4D23-B197-CDF9DF51A61C

P2093

Q37091001-02F4C45E-9503-40DF-9495-E3825F787BB8

Q37091001-099B33A8-7CCD-469F-8268-ADA425F64327

Q37091001-10E5F13E-7D26-461F-84FF-7CB56B143D2C

Q37091001-193F3662-D87E-4C26-852C-3C3985D25B6D

Q37091001-7A74F015-5D0E-4615-9BCA-B210FD1FCC58

Q37091001-98E564EB-D6FF-41E6-9DFB-E634C5024606

Q37091001-A7BBACA9-CAD9-43DA-B6C3-F35FD18E87D2

Q37091001-AC9313E7-F933-4164-BEA4-E46BCA3B6F09

Q37091001-DE012B39-89DC-492C-8B9A-55B6BD38740E

P2860

Q37091001-00D7A935-7FD6-4FE6-AB27-2AE64C90FC43

Q37091001-203CEEFC-3F9A-4686-B056-241C5F127A92

Q37091001-244103C8-1D61-4197-B90B-A903A2602692

Q37091001-2B41CFB7-5586-460C-B166-F00AE304E3F3

Q37091001-31375D46-DDD0-4566-AA1B-E84BE4B18CF2

Q37091001-35B0760F-2470-45CC-8281-39440828B91A

Q37091001-46FC5DF7-D72B-4E2D-83D9-53F7CAF216C9

Q37091001-475C7FF7-1F1B-40F2-8DEC-415AA3E38D59

Q37091001-4D040181-7F3A-4062-923F-C5FBEB95F92A

Q37091001-52824787-A5D7-4FB8-ADAB-FA56BD759359

P304

Q37091001-21AE9801-DE5B-4216-8EF2-0D27185812FD

P31

Q37091001-39E2E7CD-F1BB-4C05-BC92-E724225A4655

P356

Q37091001-FA25F17B-3315-4032-8761-9B6BBC786227

P433

Q37091001-8409C948-7ABB-4D3E-9615-621EB5EBA65B

P478

Q37091001-A30C444A-5C26-4E8A-B89A-9D1D2591A033

P577

Q37091001-CB6077F1-71CD-4298-8E25-4295B9D5C6ED

P5875

Q37091001-ED1649A0-3952-490E-8E47-036E6A76DABA

P698

Q37091001-B0C27867-0E49-4F17-8602-5485784BD33E

P921

Q37091001-77628A05-6572-4FB1-A859-E3DA5DC84F07

P932

Q37091001-E1F49109-0A67-49B6-B643-C9CBB7A95FAF

P356

P1433

European Journal of Heart Failure

P1476

Isoproterenol-induced heart fa ...... terations of cardiac function.

@en

P2093

Andrea Gazova

http://www.w3.org/2001/XMLSchema#string

Dana Kucerova

http://www.w3.org/2001/XMLSchema#string

Jan Klimas

http://www.w3.org/2001/XMLSchema#string

Jan Kyselovic

http://www.w3.org/2001/XMLSchema#string

Jana Kmecova

http://www.w3.org/2001/XMLSchema#string

Peter Krenek

http://www.w3.org/2001/XMLSchema#string

Peter Musil

http://www.w3.org/2001/XMLSchema#string

Peter Ochodnicky

http://www.w3.org/2001/XMLSchema#string

Zuzana Bajuszova

http://www.w3.org/2001/XMLSchema#string

P2860

Role of eNOS in neovascularization: NO for endothelial progenitor cells

Experimental cardiac hypertrophy induced by isoproterenol in the rat

Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death

Nitric oxide and cardiac function: ten years after, and continuing.

Nitric oxide "at heart": emerging paradigms after a decade.

Caveolins and the regulation of endothelial nitric oxide synthase in the heart.

Expression of inducible nitric oxide synthase in failing and non-failing human heart.

Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.

Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression.

Triadin is a critical determinant of cellular Ca cycling and contractility in the heart.

P304

140-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURJHF/HFN026

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23938823

http://www.w3.org/2001/XMLSchema#string

P698

19168511

http://www.w3.org/2001/XMLSchema#string

P921

P932

2639419

http://www.w3.org/2001/XMLSchema#string